Ling Qin#


Ling Qin
Membership Number:6564
Membership type:FOREIGN
Section:CLINICAL & VETERINARY SCIENCE
Elected:2023
Main Country of Residence:CHINA
Homepage(s):http://www.ort.cuhk.edu.hk/staff-qinling.html
ORCID:0000-0001-5888-7087




Present and Previous Positions
  • 2021 - present Cho-Ming Li Professor of Orthopaedics & Traumatology, CUHK, Hong Kong
  • 2004 - present Professor, Department of Orthopaedics & Traumatology, CUHK, Hong Kong
  • 2001 - 2004 Associate Professor, Department of Orthopaedics & Traumatology, CUHK, Hong Kong
  • 1997 - 2000 Assistant Professor, Department of Orthopaedics & Traumatology, CUHK, Hong Kong
  • 1994 - 1996 Scientific Officer, Department of Orthopaedics & Traumatology, CUHK, Hong Kong
  • 1993 - 1994 Research Scientist, Dept of Traumatology, Charité - Berlin Uni of Medicine, Germany
  • 1992 - 1993 Post-doctor A)/ASIF Research Institute, Davos, Switzerland

Fields of Scholarship
  • Regeneration
  • Biodegradable materials
  • Osteonecrosis
  • Sports medicine
  • Orthopaedics
  • Osteoporosis
  • Pathophysiology
  • Fracture repair

Honours and Awards
  • 2013 Collage of Fellows of American Institute for Medical and Biological Engineering (AIMBE)
  • 2013 Prize for Progress in Science and Technology of Ministry of Education, China
  • 2016 Colleague Fellow of International Orthopaedic Research (FIOR), USA
  • 2018 Prize of Science and technology of Chinese Medical Association, China
  • 2018 Reviewer for Sartorius & Science Prize for Regenerative Medicine & Cell Therapy (Science)
  • 2019 Fellow of the American Society of Bone and Mineral Research (ASBMR), USA
  • 2020 Fellow of the International Union of Societies for Biomaterials Science and Engineering, USA
  • 2020 China Patent Award Silver Medal from Sate Intellectual Property Office, China
  • 2020 Berton Rahn Research Award, AO-Foundation, Switzerland
  • 2021 Cho-Ming Li Professor of Orthopaedics & Traumatology, CUHK, Hong Kong
  • 2022 Invention Geneva Gold Medal, Switzerland

Imprint Privacy policy « This page (revision-7) was last changed on Wednesday, 31. May 2023, 10:53 by Kaiser Dana
  • operated by